Page last updated: 2024-08-21

hematoxylin and B16 Melanoma

hematoxylin has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Y; Fu, Z; Han, R; Liu, H; Wang, F; Zhao, W1

Other Studies

1 other study(ies) available for hematoxylin and B16 Melanoma

ArticleYear
Taxol inhibits melanoma metastases through apoptosis induction, angiogenesis inhibition, and restoration of E-cadherin and nm23 expression.
    Journal of pharmacological sciences, 2003, Volume: 93, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cadherins; Coloring Agents; Eosine Yellowish-(YS); Fluorescent Dyes; Hematoxylin; Immunohistochemistry; In Situ Hybridization; In Situ Nick-End Labeling; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Electron; Neovascularization, Pathologic; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Paclitaxel; Protein Biosynthesis; RNA, Messenger; Vascular Endothelial Growth Factor A

2003